FTO is expressed at low levels in ovarian cancer stem cells (OCSC), and its overexpression inhibits OCSC proliferation, self-renewal and spherogenesis, and blocks cAMP signalling dependent on m6A demethylation [93]. Here, FTO is linked to ovarian cancer.